333 related articles for article (PubMed ID: 31693980)
1. NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.
Motzer RJ; Jonasch E; Michaelson MD; Nandagopal L; Gore JL; George S; Alva A; Haas N; Harrison MR; Plimack ER; Sosman J; Agarwal N; Bhayani S; Choueiri TK; Costello BA; Derweesh IH; Gallagher TH; Hancock SL; Kyriakopoulos C; LaGrange C; Lam ET; Lau C; Lewis B; Manley B; McCreery B; McDonald A; Mortazavi A; Pierorazio PM; Ponsky L; Redman BG; Somer B; Wile G; Dwyer MA; ; Hammond LJ; Zuccarino-Catania G
J Natl Compr Canc Netw; 2019 Nov; 17(11):1278-1285. PubMed ID: 31693980
[TBL] [Abstract][Full Text] [Related]
2. NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
Motzer RJ; Jonasch E; Agarwal N; Alva A; Bagshaw H; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Gunn A; Haas N; Johnson M; Kapur P; King J; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Sweis R; Zibelman M; Schonfeld R; Stein M; Gurski LA
J Natl Compr Canc Netw; 2024 Feb; 22(1):4-16. PubMed ID: 38394781
[TBL] [Abstract][Full Text] [Related]
3. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
Motzer RJ; Jonasch E; Boyle S; Carlo MI; Manley B; Agarwal N; Alva A; Beckermann K; Choueiri TK; Costello BA; Derweesh IH; Desai A; George S; Gore JL; Haas N; Hancock SL; Kyriakopoulos C; Lam ET; Lau C; Lewis B; Madoff DC; McCreery B; Michaelson MD; Mortazavi A; Nandagopal L; Pierorazio PM; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Somer B; Sosman J; Dwyer MA; Motter AD
J Natl Compr Canc Netw; 2020 Sep; 18(9):1160-1170. PubMed ID: 32886895
[TBL] [Abstract][Full Text] [Related]
4. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Motzer RJ; Jonasch E; Agarwal N; Alva A; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Haas N; Hancock SL; Kapur P; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Nandagopal L; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Dwyer MA; Gurski LA; Motter A
J Natl Compr Canc Netw; 2022 Jan; 20(1):71-90. PubMed ID: 34991070
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
[TBL] [Abstract][Full Text] [Related]
6. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Motzer RJ; Jonasch E; Agarwal N; Bhayani S; Bro WP; Chang SS; Choueiri TK; Costello BA; Derweesh IH; Fishman M; Gallagher TH; Gore JL; Hancock SL; Harrison MR; Kim W; Kyriakopoulos C; LaGrange C; Lam ET; Lau C; Michaelson MD; Olencki T; Pierorazio PM; Plimack ER; Redman BG; Shuch B; Somer B; Sonpavde G; Sosman J; Dwyer M; Kumar R
J Natl Compr Canc Netw; 2017 Jun; 15(6):804-834. PubMed ID: 28596261
[TBL] [Abstract][Full Text] [Related]
7. Kidney cancer, version 3.2015.
Motzer RJ; Jonasch E; Agarwal N; Beard C; Bhayani S; Bolger GB; Chang SS; Choueiri TK; Costello BA; Derweesh IH; Gupta S; Hancock SL; Kim JJ; Kuzel TM; Lam ET; Lau C; Levine EG; Lin DW; Michaelson MD; Olencki T; Pili R; Plimack ER; Rampersaud EN; Redman BG; Ryan CJ; Sheinfeld J; Shuch B; Sircar K; Somer B; Wilder RB; Dwyer M; Kumar R;
J Natl Compr Canc Netw; 2015 Feb; 13(2):151-9. PubMed ID: 25691606
[TBL] [Abstract][Full Text] [Related]
8. Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
Goebell PJ; Ivanyi P; Bedke J; Bergmann L; Berthold D; Boegemann M; Busch J; Doehn C; Krege S; Retz M; Amsberg GV; Grimm MO; Gruenwald V
Future Oncol; 2020 Oct; 16(29):2307-2328. PubMed ID: 32964728
[TBL] [Abstract][Full Text] [Related]
9. What Do International Guidelines Say About First-line Therapy for Clear-cell Metastatic Renal Cell Carcinoma?
Thana M; Wood LA
Eur Urol Focus; 2020 Jan; 6(1):48-52. PubMed ID: 31629680
[TBL] [Abstract][Full Text] [Related]
10. NCCN practice guidelines for kidney cancer. National Comprehensive Cancer Network.
Oncology (Williston Park); 1998 Nov; 12(11A):396-412. PubMed ID: 10028523
[No Abstract] [Full Text] [Related]
11. NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy.
Hudes GR; Carducci MA; Choueiri TK; Esper P; Jonasch E; Kumar R; Margolin KA; Michaelson MD; Motzer RJ; Pili R; Roethke S; Srinivas S
J Natl Compr Canc Netw; 2011 Feb; 9 Suppl 1(0 1):S1-29. PubMed ID: 21335444
[TBL] [Abstract][Full Text] [Related]
12. NCCN clinical practice guidelines in oncology: kidney cancer.
Motzer RJ; Agarwal N; Beard C; Bolger GB; Boston B; Carducci MA; Choueiri TK; Figlin RA; Fishman M; Hancock SL; Hudes GR; Jonasch E; Kessinger A; Kuzel TM; Lange PH; Levine EG; Margolin KA; Michaelson MD; Olencki T; Pili R; Redman BG; Robertson CN; Schwartz LH; Sheinfeld J; Wang J
J Natl Compr Canc Netw; 2009 Jun; 7(6):618-30. PubMed ID: 19555584
[No Abstract] [Full Text] [Related]
13. NCCN Guidelines Updates: Management of Metastatic Kidney Cancer.
Jonasch E
J Natl Compr Canc Netw; 2019 May; 17(5.5):587-589. PubMed ID: 31117033
[TBL] [Abstract][Full Text] [Related]
14. NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Dilling T; Dobelbower M; Govindan R; Hennon M; Horn L; Jahan TM; Komaki R; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Sharma N; Swanson SJ; Stevenson J; Tauer K; Yang SC; Gregory K; Hughes M
J Natl Compr Canc Netw; 2016 Jul; 14(7):825-36. PubMed ID: 27407123
[TBL] [Abstract][Full Text] [Related]
15. Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma.
Christensen BR; Hajja YM; Koshkin V; Barata PC
Curr Treat Options Oncol; 2021 Jan; 22(2):15. PubMed ID: 33438115
[TBL] [Abstract][Full Text] [Related]
16. Updates to the Management of Kidney Cancer.
Jonasch E
J Natl Compr Canc Netw; 2018 May; 16(5S):639-641. PubMed ID: 29784745
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the Management of Rare Kidney Cancers.
Giles RH; Choueiri TK; Heng DY; Albiges L; Hsieh JJ; Linehan WM; Pal S; Maskens D; Paseman B; Jonasch E; Malouf G; Molina AM; Pickering L; Shuch B; Srinivas S; Srinivasan R; Tannir NM; Bex A
Eur Urol; 2017 Dec; 72(6):974-983. PubMed ID: 28720391
[TBL] [Abstract][Full Text] [Related]
18. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Ljungberg B; Albiges L; Abu-Ghanem Y; Bensalah K; Dabestani S; Fernández-Pello S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Kuusk T; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Tahbaz R; Volpe A; Bex A
Eur Urol; 2019 May; 75(5):799-810. PubMed ID: 30803729
[TBL] [Abstract][Full Text] [Related]
19. [Clinical recommendations for treating and monitoring patients with renal cancer].
Petković M; Vrdoljak E; Ruzić IP; Belev B; Omrcen T; Ledina D; Tomek R; Ruzić B; Situm M; Buća A; Pisac VP;
Lijec Vjesn; 2012; 134(1-2):5-8. PubMed ID: 22519246
[TBL] [Abstract][Full Text] [Related]
20. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA
J Natl Compr Canc Netw; 2013 Feb; 11(2):141-52; quiz 152. PubMed ID: 23411381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]